Elisabeth Sandoval's Net Worth
$5.11 Million
Who is Elisabeth Sandoval?
Elisabeth Sandoval has an estimated net worth of $5.11 Million. This is based on reported shares across multiple companies, which include KYTHERA BIOPHARMACEUTICALS INC, ALDER BIOPHARMACEUTICALS INC, Intersect ENT, Inc., VYNE Therapeutics Inc., Satsuma Pharmaceuticals, Inc., and PROCEPT BioRobotics Corp.
SEC CIK
Elisabeth Sandoval's CIK is 0001632295
Past Insider Trading and Trends
2015 was Elisabeth Sandoval's most active year for acquiring shares with 8 total transactions. Elisabeth Sandoval's most active month to acquire stocks was the month of May. 2015 was Elisabeth Sandoval's most active year for disposing of shares, totalling 18 transactions. Elisabeth Sandoval's most active month to dispose stocks was the month of August. 2015 saw Elisabeth Sandoval paying a total of $1,599,136.84 for 178,192 shares, this is the most they've acquired in one year. In 2015 Elisabeth Sandoval cashed out on 284,441 shares for a total of $6,505,095.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
KYTHERA BIOPHARMACEUTICALS INC No price found
Chief Commerical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -575.00 |
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
$47.07 | -$4,626,700.96 |
0
|
Sep 22 - Sep 23
| |||
Form 4
| -100.00% | -2.73K |
$74.75 | -$203,918.00 |
0
|
Aug 5
| |||
Form 4
|
∞
| 2.73K |
$45.55 | -$75,339.70 | 2.73K |
Apr 29 - Apr 30
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALDER BIOPHARMACEUTICALS INC No price found
CCO & EVP, Corporate Strategy
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intersect ENT, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VYNE Therapeutics Inc. (VYNE) Snapshot price: $2.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Satsuma Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||